Volume 21, Number 1—January 2015
Dispatch
Use of Treponema pallidum PCR in Testing of Ulcers for Diagnosis of Primary Syphilis1
Table 2
Reference testing, n = 170 | Sensitivity (95% CI) | Specificity (95% CI) | Likelihood ratios (95% CI) |
κ coefficient | Post-test probability (95% CI) |
||
---|---|---|---|---|---|---|---|
Positive | Negative | If Tp-PCR is positive (PPV) | If Tp-PCR is negative (1 − NPV) | ||||
Tp-PCR | 69.8% (53.9%–82.8%) | 98.4% (94.4%–99.6%) | 44.30 (11.05–177.68) | 0.31 (0.20–0.48) | 0.74 (0.62–0.87) | 93.8% (79.2%–99.2%) | 9.4% (5.6%–15.4%) |
Enhanced definition | 66.7% (51.6%–79.6%) | 100.0% (96.9%–100.0%) | 163.33 (10.2–2615.37) | 0.33 (0.22–0.50) | 0.74 (0.62–0.86) | 100.0% (89.3%–100.0%) | 11.6% (7.3%–18.0%) |
*Tp-PCR, Treponema pallidum PCR; DFM, darkfield microscopy; PPV, positive predictive value; NVP, negative predictive value.
1Preliminary results from this study were presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy, September 10–13, 2013, Denver, Colorado, USA.
Page created: December 19, 2014
Page updated: December 19, 2014
Page reviewed: December 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.